Insider filing
Traded Sep 1 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Aug 14, 2026 · Filed Aug 17, 2026
Charles Schwab's MD, Head of Retail Investing sold $2.43M of Charles Schwab shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$2,427,688
Shares × reported transaction price
24 days after results of Jul 21, 2026, 62 days before results of Oct 15, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $111.09 on Aug 14, 2026, at its 52-week high, after a 15% rise over the previous 30 trading days
52-week range $85.35 (May 28, 2026) to $111.09 (Aug 14, 2026), 100% of the way up, from 251 adjusted closes. 30 trading days earlier: $97.00 on Jul 2, 2026. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
A securities lawsuit naming the company as a defendant was filed on Oct 6, 2025 in the U.S. District Court, E.D. Texas. A filing is an allegation, not a finding.
Lewis v. Charles Schwab & Co., Inc., docket 4:25-cv-01086, via CourtListener (court records). Nature of suit 850, company named as first defendant
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +0.5% | −0.2% | +0.7% |
| 30 days | −6.3% | −0.6% | −5.7% |
| 90 days | −16.8% | −3.6% | −13.2% |
Past results only. Not a forecast.
Insider filing
Traded Sep 1 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Neesha Hathi (MD, Head Wealth Adv, Bnk, Tst) sold ~$346K of Charles Schwab Corporation
Planned saleInsider filing
Traded Sep 1 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.